Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings

Benoît Brilland, Jean-François Augusto

Open source

DOI
10.1016/j.ekir.2026.106535
Published
2026-07
Container
Kidney International Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.106535,
  title = {Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings},
  author = {Benoît Brilland and Jean-François Augusto},
  year = {2026},
  journal = {Kidney International Reports},
  doi = {10.1016/j.ekir.2026.106535},
  url = {https://doi.org/10.1016/j.ekir.2026.106535}
}

RIS

TY  - JOUR
TI  - Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings
AU  - Benoît Brilland
AU  - Jean-François Augusto
PY  - 2026
JO  - Kidney International Reports
DO  - 10.1016/j.ekir.2026.106535
UR  - https://doi.org/10.1016/j.ekir.2026.106535
ER  - 

APA

Brilland, B., & Augusto, J. (2026). Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings. Kidney International Reports. https://doi.org/10.1016/j.ekir.2026.106535

Source records